Axa’s Monster Beverage MNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
18,070
-1,800
-9% -$142K 0.51% 27
2025
Q4
$1.52M Sell
19,870
-3,417
-15% -$245K 0.72% 29
2025
Q3
$1.57M Sell
23,287
-572,503
-96% -$35.7M 0.79% 28
2025
Q2
$37.3M Buy
595,790
+3,918
+0.7% +$239K 0.11% 175
2025
Q1
$34.6M Buy
591,872
+15,732
+3% +$820K 0.11% 184
2024
Q4
$30.3M Sell
576,140
-19,447
-3% -$1.03M 0.09% 210
2024
Q3
$31.1M Buy
595,587
+14,674
+3% +$727K 0.09% 210
2024
Q2
$29M Buy
580,913
+1,528
+0.3% +$81K 0.09% 214
2024
Q1
$34.3M Sell
579,385
-22,201
-4% -$1.28M 0.1% 199
2023
Q4
$34.7M Sell
601,586
-31,836
-5% -$1.7M 0.11% 188
2023
Q3
$33.5M Buy
633,422
+43,778
+7% +$2.49M 0.12% 186
2023
Q2
$33.9M Sell
589,644
-65,948
-10% -$3.75M 0.11% 200
2023
Q1
$35.4M Buy
655,592
+188,714
+40% +$9.68M 0.12% 197
2022
Q4
$23.7M Sell
466,878
-59,286
-11% -$2.87M 0.09% 272
2022
Q3
$22.9M Sell
526,164
-367,042
-41% -$16.9M 0.09% 258
2022
Q2
$41.4M Sell
893,206
-14,616
-2% -$636K 0.15% 154
2022
Q1
$36.3M Sell
907,822
-30,260
-3% -$1.27M 0.1% 231
2021
Q4
$45M Sell
938,082
-125,084
-12% -$5.56M 0.12% 207
2021
Q3
$47.2M Sell
1,063,166
-3,028
-0.3% -$143K 0.13% 190
2021
Q2
$48.7M Buy
1,066,194
+37,786
+4% +$1.77M 0.14% 176
2021
Q1
$46.8M Sell
1,028,408
-124,060
-11% -$5.56M 0.14% 180
2020
Q4
$53.3M Sell
1,152,468
-576,320
-33% -$24.2M 0.17% 141
2020
Q3
$69.3M Buy
1,728,788
+668,460
+63% +$26.4M 0.25% 91
2020
Q2
$36.8M Buy
1,060,328
+174,460
+20% +$5.7M 0.14% 166
2020
Q1
$24.9M Sell
885,868
-12,426
-1% -$399K 0.12% 194
2019
Q4
$28.5M Buy
898,294
+1,538
+0.2% +$45.2K 0.12% 220
2019
Q3
$26M Buy
896,756
+79,072
+10% +$2.4M 0.1% 248
2019
Q2
$26.1M Sell
817,684
-8,892
-1% -$268K 0.1% 257
2019
Q1
$22.6M Sell
826,576
-29,818
-3% -$850K 0.09% 275
2018
Q4
$21.1M Sell
856,394
-85,418
-9% -$2.32M 0.09% 264
2018
Q3
$27.4M Sell
941,812
-1,260,940
-57% -$37.9M 0.1% 243
2018
Q2
$63.1M Buy
2,202,752
+161,524
+8% +$4.36M 0.24% 118
2018
Q1
$58.4M Buy
2,041,228
+127,000
+7% +$3.97M 0.23% 114
2017
Q4
$60.6M Buy
1,914,228
+87,918
+5% +$2.63M 0.24% 120
2017
Q3
$50.5M Sell
1,826,310
-152,228
-8% -$4.1M 0.22% 135
2017
Q2
$49.1M Sell
1,978,538
-27,386
-1% -$660K 0.22% 130
2017
Q1
$46.3M Sell
2,005,924
-288,290
-13% -$6.44M 0.21% 145
2016
Q4
$50.9M Buy
2,294,214
+127,146
+6% +$2.91M 0.24% 123
2016
Q3
$53M Sell
2,167,068
-8,400
-0.4% -$218K 0.23% 129
2016
Q2
$58.3M Sell
2,175,468
-265,200
-11% -$6.4M 0.26% 114
2016
Q1
$54.3M Buy
2,440,668
+8,328
+0.3% +$185K 0.24% 117
2015
Q4
$60.4M Sell
2,432,340
-115,686
-5% -$2.79M 0.26% 108
2015
Q3
$57.4M Sell
2,548,026
-1,016,736
-29% -$23.8M 0.24% 114
2015
Q2
$79.6M Buy
3,564,762
+2,455,326
+221% +$54.8M 0.32% 82
2015
Q1
$25.6M Sell
1,109,436
-181,200
-14% -$3.79M 0.11% 221
2014
Q4
$23.3M Sell
1,290,636
-178,200
-12% -$3.07M 0.09% 238
2014
Q3
$22.4M Buy
1,468,836
+682,836
+87% +$8.96M 0.1% 238
2014
Q2
$9.3M Sell
786,000
-228,000
-22% -$2.6M 0.04% 416
2014
Q1
$11.7M Hold
1,014,000
0.05% 347
2013
Q4
$11.5M Buy
1,014,000
+12,000
+1% +$118K 0.05% 351
2013
Q3
$8.73M Hold
1,002,000
0.04% 389
2013
Q2
$10.1M Buy
+1,002,000
New +$9.41M 0.05% 331

Other funds holding MNST

Axa's MNST Position: Q1 2026 in Review

Axa reduced its Monster Beverage (MNST) stake by 9.1% in Q1 2026, selling an estimated $142K and leaving 18,070 shares worth $1.31M. The position accounts for 0.51% of the portfolio, ranked #27.

Axa first reported a position in MNST in Q2 2013 and has held it in 52 quarters since. The position peaked at $79.6M in Q2 2015. 1,236 funds tracked by Wall St. Rank hold MNST as of Q1 2026.

  • Axa held 18,070 shares of Monster Beverage worth $1.31M as of Q1 2026.
  • Axa sold 1,800 Monster Beverage shares in Q1 2026, an estimated $142K.
  • Monster Beverage made up 0.51% of Axa's portfolio in Q1 2026, its #27 holding.
  • Axa first reported a position in Monster Beverage in Q2 2013 and has held it in 52 quarters since.
  • Axa's Monster Beverage position peaked at $79.6M in Q2 2015.
  • 1,236 funds tracked by Wall St. Rank held Monster Beverage as of Q1 2026.

Based on Axa's 13F filing for Q1 2026, filed 15 May 2026.